Mission Wealth Management
GPCR icon

Mission Wealth Management’s Structure Therapeutics GPCR Stock Holding History

Mission Wealth Management’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$237K Hold
7,583
– – ﹤0.01% 714
2026
Q2 		$407K Hold
7,583
– – 0.01% 760
2026
Q1 		$366K Sell
7,583
-2,000
-21% -$137K 0.01% 568
2025
Q4 		$666K Hold
9,583
– – 0.01% 420
2025
Q3 		$268K Buy
+9,583
New +$191K 0.01% 613

Other funds holding GPCR

Exchange Traded Concepts
Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return
Private Capital Advisors
Private Capital Advisors Darien, Connecticut $1.15B AUM 43.46% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Mitsubishi UFJ Asset Management (UK)
Mitsubishi UFJ Asset Management (UK) London, United Kingdom $213M AUM 36.38% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
State of Wyoming
State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return
GF Fund Management
GF Fund Management Guangzhou, China $7.72B AUM 122.96% 1-Year Est. Return

Mission Wealth Management's GPCR Position: Q3 2026 in Review

Mission Wealth Management held its Structure Therapeutics (GPCR) position steady in Q3 2026 at 7,583 shares worth $237K. The position accounts for ﹤0.01% of the portfolio, ranked #714.

Mission Wealth Management first reported a position in GPCR in Q3 2025 and has held it in 5 quarters since. The position peaked at $666K in Q4 2025. 22 funds tracked by Wall St. Rank hold GPCR as of Q3 2026.

  • Mission Wealth Management held 7,583 shares of Structure Therapeutics worth $237K as of Q3 2026.
  • Mission Wealth Management left its Structure Therapeutics share count unchanged in Q3 2026.
  • Structure Therapeutics made up ﹤0.01% of Mission Wealth Management's portfolio in Q3 2026, its #714 holding.
  • Mission Wealth Management first reported a position in Structure Therapeutics in Q3 2025 and has held it in 5 quarters since.
  • Mission Wealth Management's Structure Therapeutics position peaked at $666K in Q4 2025.
  • 22 funds tracked by Wall St. Rank held Structure Therapeutics as of Q3 2026.

Based on Mission Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.